Pmv Pharmaceuticals Inc (PMVP) Insider Trading
- $17,100,000.00
- $39,540,718.66
- July 1, 2025
- Thilo Schroeder
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
July 1, 2025 | COO | 23,151 | $1.06 | Sell | $24,540.06 | |
July 1, 2025 | CEO | 58,411 | $1.06 | Sell | $61,915.66 | |
July 1, 2025 | Insider | 33,065 | $1.06 | Sell | $35,048.90 | |
Sept. 11, 2024 | Insider | 7,218 | $1.50 | Sell | $10,827.00 | |
Sept. 11, 2024 | CFO | 2,891 | $1.50 | Sell | $4,336.50 | |
Nov. 22, 2023 | Major Shareholder | 87,786 | $2.23 | Sell | $195,762.78 | |
Sept. 15, 2023 | Insider | 4,104 | $6.62 | Sell | $27,168.48 | |
May 26, 2022 | Major Shareholder | 26,253 | $15.93 | Sell | $418,210.29 | |
March 31, 2022 | Major Shareholder | 34,500 | $21.17 | Sell | $730,365.00 | |
March 29, 2022 | Major Shareholder | 365,000 | $21.52 | Sell | $7,854,800.00 | |
Oct. 6, 2021 | Director | 800 | $30.15 | Sell | $24,120.00 | |
Oct. 4, 2021 | Director | 100 | $30.08 | Sell | $3,008.00 | |
Oct. 1, 2021 | Director | 11,541 | $30.10 | Sell | $347,384.10 | |
Sept. 29, 2021 | Director | 5,708 | $30.04 | Sell | $171,468.32 | |
Sept. 27, 2021 | Director | 1,753 | $30.11 | Sell | $52,782.83 | |
Sept. 22, 2021 | Director | 3,500 | $30.00 | Sell | $105,000.00 | |
Sept. 17, 2021 | Director | 711 | $30.03 | Sell | $21,351.33 | |
Sept. 13, 2021 | Director | 13,272 | $30.20 | Sell | $400,814.40 | |
Sept. 9, 2021 | Director | 14,329 | $30.31 | Sell | $434,311.99 | |
Sept. 7, 2021 | Insider | 3,900 | $30.25 | Sell | $117,975.00 | |
Sept. 1, 2021 | Director | 21,986 | $30.38 | Sell | $667,934.68 | |
Aug. 30, 2021 | Director | 13,233 | $30.05 | Sell | $397,651.65 | |
Aug. 27, 2021 | Director | 24,442 | $30.52 | Sell | $745,969.84 | |
Aug. 25, 2021 | Director | 13,526 | $31.01 | Sell | $419,441.26 | |
Aug. 23, 2021 | Director | 3,500 | $29.50 | Sell | $103,250.00 | |
Aug. 18, 2021 | Director | 26,864 | $33.34 | Sell | $895,645.76 | |
Aug. 16, 2021 | Director | 22,183 | $33.89 | Sell | $751,781.87 | |
Aug. 13, 2021 | Director | 27,286 | $34.24 | Sell | $934,272.64 | |
Aug. 11, 2021 | Director | 34,439 | $34.04 | Sell | $1,172,303.56 | |
Aug. 9, 2021 | Insider | 4,471 | $34.04 | Sell | $152,192.84 | |
Aug. 9, 2021 | Director | 22,182 | $35.53 | Sell | $788,126.46 | |
Aug. 6, 2021 | Director | 19,900 | $36.61 | Sell | $728,539.00 | |
Aug. 4, 2021 | Director | 52,860 | $35.85 | Sell | $1,895,031.00 | |
Aug. 3, 2021 | CFO | 4,500 | $33.82 | Sell | $152,190.00 | |
Aug. 2, 2021 | Director | 13,031 | $34.74 | Sell | $452,696.94 | |
July 28, 2021 | Director | 8,724 | $35.76 | Sell | $311,970.24 | |
July 26, 2021 | Director | 4,839 | $35.73 | Sell | $172,897.47 | |
July 22, 2021 | Director | 200 | $35.61 | Sell | $7,122.00 | |
July 20, 2021 | CEO | 1,029 | $35.53 | Sell | $36,560.37 | |
July 20, 2021 | Director | 3,500 | $35.12 | Sell | $122,920.00 | |
July 8, 2021 | CFO | 4,500 | $33.75 | Sell | $151,875.00 | |
July 7, 2021 | Insider | 4,000 | $32.30 | Sell | $129,200.00 | |
June 28, 2021 | CEO | 204 | $35.53 | Sell | $7,248.12 | |
June 21, 2021 | Director | 3,500 | $33.25 | Sell | $116,375.00 | |
June 14, 2021 | Major Shareholder | 44,419 | $34.11 | Sell | $1,515,132.09 | |
June 11, 2021 | Major Shareholder | 21,977 | $33.80 | Sell | $742,822.60 | |
June 9, 2021 | Major Shareholder | 39,638 | $33.64 | Sell | $1,333,422.32 | |
June 7, 2021 | Insider | 4,000 | $33.60 | Sell | $134,400.00 | |
June 7, 2021 | Major Shareholder | 30,721 | $33.62 | Sell | $1,032,840.02 | |
June 4, 2021 | CFO | 4,500 | $33.75 | Sell | $151,875.00 |
Insiders are both buying and selling Pmv Pharmaceuticals Inc stock.
The insider traders at Pmv Pharmaceuticals Inc are: Thilo Schroeder, Leila Alland, Orbimed Advisors Llc, David Henry Mack, Winston Kung, Euclidean Capital Llc, Arnold J Levine, Deepika Jalota, Arnold J. Levine, Ra Capital Management, L.P., Richard A Heyman, Robert Ticktin, and Michael Carulli
The most active insider trader at Pmv Pharmaceuticals Inc is Thilo Schroeder with 35 trades.
Thilo Schroeder has sold the most Pmv Pharmaceuticals Inc stock with a total value of $23,200,568.66.
Ra Capital Management, L.P. has bought the most Pmv Pharmaceuticals Inc stock with a total value of $34,200,000.00.
The most recent insider trade for Pmv Pharmaceuticals Inc was on July 1, 2025.
The single biggest insider buy for Pmv Pharmaceuticals Inc was from Ra Capital Management, L.P. with a total value of $17,100,000.00 on Sept. 29, 2020.
The single biggest insider sell for Pmv Pharmaceuticals Inc was from Orbimed Advisors Llc with a total value of $7,854,800.00 on March 29, 2022.